Masimo Ownership
MASI Stock | USD 159.45 0.59 0.37% |
Shares in Circulation | First Issued 1999-09-30 | Previous Quarter 53.6 M | Current Value 54.8 M | Avarage Shares Outstanding 51.3 M | Quarterly Volatility 13.9 M |
Masimo Stock Ownership Analysis
About 92.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.46. Masimo last dividend was issued on the 23rd of November 2012. Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company was incorporated in 1989 and is headquartered in Irvine, California. Masimo Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 2200 people. To find out more about Masimo contact Joseph Kiani at 949 297 7000 or learn more at https://www.masimo.com.Besides selling stocks to institutional investors, Masimo also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Masimo's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Masimo's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Masimo Quarterly Liabilities And Stockholders Equity |
|
Masimo Insider Trades History
About 8.0% of Masimo are currently held by insiders. Unlike Masimo's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Masimo's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Masimo's insider trades
Masimo Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Masimo is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Masimo backward and forwards among themselves. Masimo's institutional investor refers to the entity that pools money to purchase Masimo's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Geode Capital Management, Llc | 2025-03-31 | 844.3 K | Liontrust Investment Partners Llp | 2025-03-31 | 747.5 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 735.8 K | Alyeska Investment Group, L.p. | 2025-03-31 | 722.5 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 703.4 K | Rtw Investments, Llc | 2025-03-31 | 683.3 K | Westfield Capital Management Company, L.p. | 2025-03-31 | 671.5 K | Schroder Investment Management Group | 2025-03-31 | 435.5 K | Northern Trust Corp | 2025-03-31 | 383.4 K | Blackrock Inc | 2025-03-31 | 9.9 M | Fmr Inc | 2025-03-31 | 8.2 M |
Masimo Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Masimo insiders, such as employees or executives, is commonly permitted as long as it does not rely on Masimo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Masimo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Masimo's latest congressional trading
Congressional trading in companies like Masimo, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Masimo by those in governmental positions are based on the same information available to the general public.
2022-11-10 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
2022-11-09 | Senator Tommy Tuberville | Acquired Under $15K | Verify |
Masimo Outstanding Bonds
Masimo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Masimo uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Masimo bonds can be classified according to their maturity, which is the date when Masimo has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Masimo Corporate Filings
F4 | 3rd of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
26th of June 2025 Other Reports | ViewVerify | |
8K | 12th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 7th of May 2025 An amendment to a previously filed Form 8-K | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Masimo offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Masimo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Masimo Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Masimo Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Masimo. If investors know Masimo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Masimo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.10) | Earnings Share (5.46) | Revenue Per Share | Quarterly Revenue Growth 0.095 | Return On Assets |
The market value of Masimo is measured differently than its book value, which is the value of Masimo that is recorded on the company's balance sheet. Investors also form their own opinion of Masimo's value that differs from its market value or its book value, called intrinsic value, which is Masimo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Masimo's market value can be influenced by many factors that don't directly affect Masimo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Masimo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Masimo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Masimo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.